On August 4-5, the 6th Biomedical Innovation Cooperation Conference and the 2022 China Biomedical Industry Value List Awards Ceremony were held at the Kempinski Hotel Suzhou Jinji Lake. The conference...
On July 22-23, 2022, the first International MAH (Marketing Authorization Holder) Cooperation and Innovation Summit was held in Hangzhou.This conference focused on the MAH system, and centered around ...
Innovation breaks through CGT, and the wind and clouds gather at East Taihu Lake! A year ago, Spectrum Bio and Tong Xieyi hosted the "East Taihu Cell and Gene Therapy Industrialization Developmen...
This morning (June 28), the ribbon-cutting ceremony for the official operation of Spectrum Biotechnology R&D Center was held. Gu Hongjian, member of the Party Working Committee and deputy director...
Recently, Jiangsu Puxin Biopharmaceutical Co., Ltd. (hereinafter referred to as "Puxin Biopharmaceutical") and Maoxing Biopharmaceutical Technology Co., Ltd. (hereinafter referred to as &quo...
Chronic lymphocytic leukemia (CLL) is a mature B lymphocyte clonal proliferation tumor that mainly occurs in the middle-aged and elderly population. Its overall incidence rate is increasing due to the...
Jiangsu Puxin Biopharmaceutical Co., Ltd. ("Puxin Bio" or "the Company") has continued to attract capital attention within two months after the completion of the Pre-A round of fin...
In order to fully grasp the progress of clinical trials for new drug registration in China, use information technology to improve drug regulatory capabilities, and timely disclose clinical trial progr...
In order to encourage the development of drugs for rare diseases and guide applicants to improve R&D efficiency from the perspective of clinical research methodology, the Drug Evaluation Center or...
In order to standardize and guide the pharmaceutical research and development, production and registration of in vivo gene therapy products, under the deployment of the National Medical Products Admin...
In order to standardize and guide the pharmaceutical research of in vitro gene modification systems, under the deployment of the National Drug Administration, the Drug Evaluation Center organized the ...
400-900-1882 
info@hillgene.com 
English
